Market Research Logo

Global Cancer Vaccines Market 2015-2019

Global Cancer Vaccines Market 2015-2019

About Cancer Vaccines

Cancer vaccines are biological preparations that stimulate or strengthen a person’s immune system against cancer. Cancer vaccines are usually administered intravenously. They can be used in both adults and children. The vaccines can be broadly classified into two: prophylactic and therapeutic vaccines. Prophylactic vaccines are used for the prevention of cancer, whereas therapeutic vaccines are used for treatment of cancer.

Technavio's analysts forecast the global cancer vaccines market to grow at a CAGR of 27.24% over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the global cancer vaccines market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various therapeutic and prophylactic cancer vaccines.This report covers the present scenario and the growth prospects of the global cancer vaccines market for the period 2015-2019 in the following three regions:

  • Americas: The principal countries focused upon in this region are the US, Canada, Mexico, and Brazil
  • EMEA: The principal countries focused upon in this region are the UK; Germany; Italy; France; Spain and Middle Eastern and African countries such as Israel, South Africa, Egypt, Sudan, Kuwait, Saudi Arabia, Qatar, and UAE
  • APAC: The principal countries focused upon in this region are Japan, China, Australia, Singapore, South Korea, and India. APAC is one of the major markets that is untapped by the leading vendors
The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the market. In addition, it discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.

Technavio's report, Global Cancer Vaccines Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, EMEA, and APAC; it also covers the global cancer vaccines market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions
  • Americas
  • APAC
  • EMEA
Key Vendors
  • Dendreon
  • GlaxoSmithKline
  • Merck
Other Prominent Vendors
  • Aduro BioTech
  • Advantagene
  • Advaxis
  • Agenus
  • AlphaVax
  • Altor BioScience
  • Amgen
  • Antigen Express
  • Argos Therapeutics
  • AVAX Technologies
  • Bavarian Nordic
  • Biothera
  • Bristol-Myers Squibb
  • Celldex Therapeutics
  • Cel-Sci
  • CureVac
  • Cytos
  • Galena Biopharma
  • Genexine
  • GlobeImmune
  • Gradalis
  • Heat Biologics
  • Immatics
  • ImmunoCellular Therapeutics
  • Immutep
  • Inovio Pharmaceuticals
  • Isa Pharmaceuticals
  • Juvaris Biotherapeutics
  • MedImmune
  • NewLink Genetics
  • Northwest Biotherapeutics
  • NovaRx
  • OncoThyreon
  • Oncovir
  • Oxford BioMedica
  • Prima BioMed
  • Progenics
  • Provectus Biopharmaceuticals
  • Sanofi
  • Sotio
  • Transgene
  • Ubivac
  • Vaccinogen
  • Vaxon Biotech
  • Vical
Market Driver
  • Increased Prevalence of Cancers
  • For a full, detailed list, view our report
Market Challenge
  • Cold Chain Management
  • For a full, detailed list, view our report
Market Trend
  • Strategic Alliances
  • For a full, detailed list, view our report
Key Questions Answered in this Report
  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Cancer Vaccines Market 2015-2019

Technavio recognizes the following companies as the key players in the global cancer vaccines market: Dendreon, GlaxoSmithKline and Merck

Other Prominent Vendors in the market are: Aduro BioTech, Advantagene, Advaxis, Agenus, AlphaVax, Altor BioScience, Amgen, Antigen Express, Argos Therapeutics, AVAX Technologies, Bavarian Nordic, Biothera, Bristol-Myers Squibb, Celldex Therapeutics, Cel-Sci, CureVac, Cytos, Galena Biopharma, Genexine, GlobeImmune, Gradalis, Heat Biologics, Immatics, ImmunoCellular Therapeutics, Immutep, Inovio Pharmaceuticals, Isa Pharmaceuticals, Juvaris Biotherapeutics, MedImmune, NewLink Genetics, Northwest Biotherapeutics, NovaRx, OncoThyreon, Oncovir, Oxford BioMedica, Prima BioMed, Progenics, Provectus Biopharmaceuticals, Sanofi, Sotio, Transgene, Ubivac, Vaccinogen, Vaxon Biotech and Vical

Commenting on the report, an analyst from Technavio’s team said: “Strategic alliances not only help a vendor increase its market penetration but they also enhance the vendor's product portfolio. For instance, GAVI Alliance aims to immunize about 2-million females in developing regions in 2015 using the HPV vaccines Cervarix and Gardasil, which are supplied at a low cost by GlaxoSmithKline and Merck. In 2015, Bristol-Myers Squibb collaborated with Bavarian Nordic to develop Prostvac, a therapeutic vaccine for the treatment of prostate cancer. Together, in 2015, Advaxis and Incyte evaluated ADXS-HPV using Incyte's investigational oral indoleamine 2,3-dioxygenase 1 inhibitor, epacadostat. In 2014, Boehringer Ingelheim and CureVac entered into an agreement to develop and commercialize a lung cancer vaccine — CV9202 — using CureVac’s RNA technology, RNActive.”

According to the report, cancer is a leading cause of deaths worldwide. According to the World Health Organization, 14-million incidences of cancer and 8.2-million cancer deaths were recorded in 2012. Lung, prostate, colorectal, cervical, and breast cancers remain the most common forms of cancer. Thus, there is a rise in demand for vaccines to prevent and treat cancers.

Further, the report states that cold chain, or temperature-controlled supply chain, management is a major challenge for this market.

Companies Mentioned

Dendreon, GlaxoSmithKline, Merck, Aduro BioTech, Advantagene, Advaxis, Agenus, AlphaVax, Altor BioScience, Amgen, Antigen Express, Argos Therapeutics, AVAX Technologies, Bavarian Nordic, Biothera, Bristol-Myers Squibb, Celldex Therapeutics, Cel-Sci, CureVac, Cytos, Galena Biopharma, Genexine, GlobeImmune, Gradalis, Heat Biologics, Immatics, ImmunoCellular Therapeutics, Immutep, Inovio Pharmaceuticals, Isa Pharmaceuticals, Juvaris Biotherapeutics, MedImmune, NewLink Genetics, Northwest Biotherapeutics, NovaRx, OncoThyreon, Oncovir, Oxford BioMedica, Prima BioMed, Progenics, Provectus Biopharmaceuticals, Sanofi, Sotio, Transgene, Ubivac, Vaccinogen, Vaxon Biotech, Vical

  • Executive Summary
  • List of Abbreviations
  • Scope of the Report
    • Market Overview
    • Product Offerings
  • Market Research Methodology
    • Market Research Process
    • Research Methodology
      • Table Market Research Methodology
  • Introduction
  • Vaccine-Approval Process
    • Table Vaccine-Approval Process
  • Market Landscape
    • Market Overview
    • Market Size and Forecast
      • Table Global Cancer Vaccines Market 2014-2019 ($ millions)
    • Five Forces Analysis
  • Market Segmentation by Application of Vaccines
    • Table Segmentation of Global Cancer Vaccines Market by Application
    • Prophylactic Cancer Vaccines
    • Therapeutic Cancer Vaccines
      • Table Segmentation of Global Cancer Vaccines Market by Application 2014
  • Global Prophylactic Cancer Vaccines Market
    • Market Overview
      • Market Size and Forecast
        • Table Global Prophylactic Cancer Vaccines Market 2014-2019 ($ millions)
  • Global Therapeutic Cancer Vaccines Market
    • Market Overview
      • Market Size and Forecast
        • Table Global Therapeutic Cancer Vaccines Market 2014-2019 ($ millions)
        • Table Global Cancer Vaccines Market 2014-2019 ($ millions)
  • Geographical Segmentation
    • Table Segmentation of the Global Cancer Vaccines Market by Region 2014
  • Buying Criteria
  • Key Brand Analysis
    • Table Global Cancer Vaccines Market: Comparison of Major Brands
    • Comparative Study between Gardasil and Cervarix
      • Table Gardasil and Cervarix: A Comparative Study
  • Pipeline Portfolio
    • Table Key Late-Stage Vaccines under Development
    • Prostvac
      • Neuvax
      • Rindopepimut
      • MVax
      • DCVax-L
      • ProstAtak
      • Talimogene Laherparepvec
      • IMA901
      • Imprime PGG
      • OncoVAX
      • Lucanix
      • DCVAC/PCa
  • Market Growth Drivers
    • Table Drivers of Global Cancer Vaccines Market
  • Drivers and Their Impact
  • Market Challenges
    • Table Challenges of Global Cancer Vaccines Market
  • Impact of Drivers and Challenges
  • Market Trends
    • Table Trends in Global Cancer Vaccines Market
  • Trends and Their Impact
  • Vendor Landscape
    • Competitive Scenario
      • Key News
      • Mergers and Acquisitions
    • Market Analysis 2014
      • Merck
        • Table Gardasil: Global Revenue and YoY Growth Rate 2010-2014
      • Dendreon
        • Table Provenge: Global Revenue and YoY Growth Rate 2011-2014
      • GlaxoSmithKline
        • Table Cervarix: Global Revenue and YoY Growth Rate 2010-2014
    • Other and Future Prominent Vendors
  • Opportunities for Cancer Vaccine Vendors
    • Table Opportunity Analysis: Global Cancer Vaccine Market
  • Key Vendor Analysis
    • Dendreon
      • Key Facts
      • Business Overview
      • Recent Developments
      • SWOT Analysis
    • GlaxoSmithKline
      • Key Facts
      • Business Overview
      • Business Segmentation by Revenue 2014
        • Table GlaxoSmithKline: Business Segmentation by Revenue 2014
      • Business Segmentation by Revenue 2013 and 2014
        • Table GlaxoSmithKline: Business Segmentation by Revenue 2013 and 2014 ($ billions)
      • Geographical Segmentation by Revenue 2014
        • Table GlaxoSmithKline: Geographical Segmentation by Revenue 2014
      • Business Strategy
      • Recent Developments
      • SWOT Analysis
    • Merck
      • Key Facts
      • Business Overview
      • Business Segmentation by Revenue 2013
        • Table Merck: Business Segmentation by Revenue 2013
      • Business Segmentation by Revenue 2012 and 2013
        • Table Merck: Business Segmentation by Revenue 2012 and 2013 ($ billions)
      • Sales by Geography
        • Table Merck: Sales by Region 2013
      • Business Strategy
      • Key Developments
      • SWOT Analysis
  • Other Reports in this Series

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report